4.8 Review

TGFβ in cancer

Journal

CELL
Volume 134, Issue 2, Pages 215-230

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2008.07.001

Keywords

-

Funding

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. NCI NIH HHS [R37 CA034610, P30 CA008748] Funding Source: Medline

Ask authors/readers for more resources

The transforming growth factor beta (TGF beta) signaling pathway is a key player in metazoan biology, and its misregulation can result in tumor development. The regulatory cytokine TGF beta exerts tumor-suppressive effects that cancer cells must elude for malignant evolution. Yet, paradoxically, TGF beta also modulates processes such as cell invasion, immune regulation, and microenvironment modification that cancer cells may exploit to their advantage. Consequently, the output of a TGF beta response is highly contextual throughout development, across different tissues, and also in cancer. The mechanistic basis and clinical relevance of TGF beta's role in cancer is becoming increasingly clear, paving the way for a better understanding of the complexity and therapeutic potential of this pathway.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available